Suchergebnisse - "F0P408N6V4"

PubPharm (31)

1

A case-control study of multiple myeloma patients with central nervous system involvement

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2022

von Li, L. | Feng, Z. | Guo, P. | +7

2

Study on the Therapeutic Effect of Lenalidomide on Hemophilic Arthropathy

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2022

von Wang, Y. | Lin, Z. | Zhang, F. | +5

3

Effect of autologous hematopoietic stem cell transplantation on minimal residual disease in patients with multiple myeloma

enthalten in: Zhonghua yi xue za zhi | 2022

von Shen, L. | Zhuansun, S. | Ni, B. | +10

4

Efficacy and prognosis of newly diagnosed multiple myeloma patients treated with bortezomib, lenalidomide and dexamethasone

enthalten in: Zhonghua yi xue za zhi | 2022

von Xu, J. | Yan, W. | Fan, H. | +7

5

Efficacy and safety of lenalidomide combined with bortezomib and dexamethasone induction therapy in newly diagnosed patients with multiple myeloma

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2022

von Yao, W. | Yan, L. | Shang, J. | +7

6

Analysis of the efficacy and survival of ixazomib-containing regimens in patients with refractory and relapsed multiple myeloma

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2022

von Yang, C. | Zhuang, J.

7

A single-center retrospective analysis of 100 consecutive cases treated with lenalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

enthalten in: Zhonghua nei ke za zhi | 2022

von Wang, W. | Bi, J. | Wen, L. | +5

8

The Clinical Characteristics and Outcomes of the Patients with POEMS Syndrome

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2021

von Wang, M. | Zhang, J. | Wan, D. | +3

9

Autologous stem cell transplantation improves outcomes of patients with multiple myeloma receiving proteasome inhibitors and lenalidomide treatment

enthalten in: Nan fang yi ke da xue xue bao = Journal of Southern Medical University | 2021

von Ning, X. | Wei, X. | Guo, X. | +8

10

The efficacy and safety profile of ixazomib/lenalidomide/dexamethasone in relapsed/refractory multiple myeloma : a multicenter real-world study in China

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2021

von Yang, Y. | Xia, Z. | Zhang, W. | +17